eNeura SpringTMS Post-Market Observational US Study of Migraine

NCT02357381 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 263

Last updated 2021-06-18

No results posted yet for this study

Summary

A multi-center, prospective, non-randomized, single arm, open label, post-market, observational study to evaluate the use of the eneura, springtms system in reduction of migraine headache symptoms.

Conditions

Interventions

DEVICE

eNeura SpringTMS

Single pulse magnetic stimulation for prevention and/or treatment of migraine headache with or without aura.

Sponsors & Collaborators

  • eNeura, Inc.

    lead INDUSTRY

Principal Investigators

  • David W Dodick, MD · Mayo Clinic , Phoenix,AZ

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-01
Primary Completion
2016-07-01
Completion
2016-07-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02357381 on ClinicalTrials.gov